Cogent Biosciences, Inc. (COGT) vs MiniMed Group, Inc. Common Stock (MMED)
A side-by-side comparison of Cogent Biosciences, Inc. and MiniMed Group, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COGT
Cogent Biosciences, Inc.
$30.37HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
MMED
MiniMed Group, Inc. Common Stock
$19.65HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — COGT vs MMED
growth of $100 · dividends reinvested · last 1yCOGT -16.6% (-16.6%/yr)MMED +9.0% (+9.0%/yr)MMED compounded faster over this window
COGT MMED
COGT vs MMED: by the numbers
- •MMED is the larger company ($5.52B vs $5.19B market cap).
- •Both run net losses; COGT's is the smaller (0.00% vs -10.21% net margin).
Metrics side by side
Valuation
| Metric | COGT | MMED |
|---|---|---|
| Forward P/E | N/A | 29.18 |
| P/S ratio | N/A | 1.71 |
| P/B ratio | 11.09 | 1.52 |
| EV / EBITDA | N/A | 30.69 |
Profitability
| Metric | COGT | MMED |
|---|---|---|
| Gross margin | 0.00% | 53.85% |
| Operating margin | 0.00% | 0.53% |
| Net margin | 0.00% | -10.21% |
| ROE | -70.85% | -9.09% |
| ROIC | -50.09% | 0.43% |
Growth (annualized)
| Metric | COGT | MMED |
|---|---|---|
| Total return CAGR (5Y) | 28.51% | N/A |
Go deeper
Dig into the metrics
Cogent Biosciences ROEMiniMed Group, Inc. Common Stock ROECogent Biosciences operating marginMiniMed Group, Inc. Common Stock operating marginCogent Biosciences revenue growthMiniMed Group, Inc. Common Stock revenue growthCogent Biosciences free cash flowMiniMed Group, Inc. Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.